MONTREAL, QUEBEC--(CCNMatthews - Feb. 21, 2007) - Not for distribution to U.S. news wire services or dissemination in the United States. Theratechnologies Inc.(TSX:TH) announced today that, further to the bought-deal financing announced on February 6, 2007, the syndicate of underwriters led by BMO Capital Markets, including Canaccord Capital, National Bank Financial, Desjardins Securities and Jennings Capital, has fully exercised its option to purchase an additional 625,000 common shares, equal to 10% of the initial offering, for purposes of covering over-allotments and for market stabilization. This brings the size of the offering to 6,875,000 common shares at a price of $8.40 per share for gross proceeds of $57,750,000. The transaction is expected to close February 27, 2007.
